Paradigm Biopharmaceuticals Ltd. (PBIGF) Receives a Buy from Bell Potter | Markets Insider

Retrieved on: 2025-02-03 00:56:57

Tags for this article:

Click the tags to see associated articles and topics

Paradigm Biopharmaceuticals Ltd. (PBIGF) Receives a Buy from Bell Potter | Markets Insider. View article details on hiswai:

Excerpt

In a report released today, John Hester from Bell Potter maintained a Buy rating on Paradigm Biopharmaceuticals Ltd. (PBIGF – Research Report), .

Article found on: markets.businessinsider.com